Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics.
作者信息
Khan Mohd Wajid Ali, Aziz Mohammad Azhar, Rajendrasozhan Saravanan
机构信息
Department of Chemistry, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Medical and Diagnostic Research Centre, University of Ha'il, Ha'il, Saudi Arabia.
出版信息
Front Immunol. 2023 Aug 22;14:1270182. doi: 10.3389/fimmu.2023.1270182. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics.
Front Immunol. 2023 Aug 22;14:1270182. doi: 10.3389/fimmu.2023.1270182. eCollection 2023.
2
Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies.
Front Immunol. 2023 Aug 11;14:1250975. doi: 10.3389/fimmu.2023.1250975. eCollection 2023.
3
Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II.
Front Immunol. 2023 Aug 11;14:1256691. doi: 10.3389/fimmu.2023.1256691. eCollection 2023.
4
Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction.
Chem Pharm Bull (Tokyo). 2018;66(8):773-778. doi: 10.1248/cpb.c17-00800.
5
Targeting Programmed Cell Death -1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy.
Pharmacol Ther. 2019 Feb;194:84-106. doi: 10.1016/j.pharmthera.2018.09.008. Epub 2018 Sep 28.
6
Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.
Front Immunol. 2023 Jun 26;14:1212209. doi: 10.3389/fimmu.2023.1212209. eCollection 2023.
7
Mechanism-directed combinational immunotherapies in liver cancer hold promise.
Cell Mol Immunol. 2023 Nov;20(11):1395-1397. doi: 10.1038/s41423-023-01068-z. Epub 2023 Aug 7.
8
Small-Molecule Drugs in Immunotherapy.
Mini Rev Med Chem. 2023;23(13):1341-1359. doi: 10.2174/1389557522666220930154527.
9
DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
J Immunother Cancer. 2021 Nov;9(11). doi: 10.1136/jitc-2021-002837.
10
[Immunotherapy in non-small cell lung cancer: inhibition of PD1/PDL1 pathway].
Rev Pneumol Clin. 2015 Feb;71(1):44-56. doi: 10.1016/j.pneumo.2014.11.004. Epub 2015 Feb 14.
Zotero 插件